Coldstream Laboratories Names Head of Formulation Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Coldstream Laboratories Names Head of Formulation Development



Untitled Document

Coldstream Laboratories, a provider of sterile drug product development and manufacturing services, has named Adrian Raiche, PhD, as director of formulation development. In this position, Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization, and scale-up activities for manufacturing in the company’s sterile manufacturing facility.

Raiche has experience in several aspects of pharmaceutical development, including lyophilization and potent compound handling.  Most recently, he served as manager of pharmaceutical development at Summit Biosciences contributing to formulation, analytical, and process development of nasal-spray products.  Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals, and Bausch and Lomb. 

Source: Coldstream Laboratories

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here